OTC Markets OTCPK - Delayed Quote USD
Avenue Therapeutics, Inc. (ATXI)
0.2081
-0.0754
(-26.59%)
At close: June 12 at 8:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DAVIDOW ROBERT L Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 11, 2023 | -- |
| FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Mar 31, 2025 | 328,524 |
| HERSKOWITZ NEIL Director | Sale | Dec 2, 2024 | 97 |
| JIN DAVID Chief Operating Officer | Stock Award(Grant) | Sep 23, 2024 | 65,000 |
| KRANZLER JAY D Director | Sale | Nov 5, 2024 | 559 |
| MACLEAN ALEXANDRA M.D. Chief Executive Officer | Stock Award(Grant) | Sep 23, 2024 | 170,000 |
| ROSENWALD LINDSAY A Director | Purchase | Sep 8, 2023 | 354,318 |
Related Tickers
APVO Aptevo Therapeutics Inc.
4.3900
-8.16%
ARMP Armata Pharmaceuticals, Inc.
1.8700
-6.97%
FBIO Fortress Biotech, Inc.
1.8500
-5.61%
KTTA Pasithea Therapeutics Corp.
0.7860
-5.21%
FBIOP Fortress Biotech, Inc.
9.02
+2.60%
PALI Palisade Bio, Inc.
0.6401
-7.23%
KZR Kezar Life Sciences, Inc.
4.5900
-4.18%
OMGAQ Omega Therapeutics, Inc.
0.0370
+32.14%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
IMRN Immuron Limited
1.7300
-1.15%